Announcements Trials
Browse Landscape

Phase

Phase 1/2 4Phase 2 3Phase 1 2

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 36Gastrointestinal 26Thoracic 10Dermatologic 10Breast 10Tumor-Agnostic 6Lymphoid 5Head & Neck 5Gynecologic 5Endocrine 4Sarcoma 3NET 3Other solid neoplasm 2CNS 2Plasma cell 1

Conditions

Osteosarcoma 1Hemangiosarcoma 1Gastrointestinal Stromal Tumors 1

Interventions

Cyclophosphamide 93Doxorubicin 92Radiotherapy 87Temozolomide 69Filgrastim 58Ifosfamide 55Bevacizumab 55Etoposide 48Gemcitabine 44Imatinib Mesylate 43Vincristine 40pembrolizumab 35pazopanib 34Peripheral Blood Stem Cell Transplantation 31Methotrexate 31Nivolumab 30Carboplatin 30fludarabine phosphate 29Irinotecan 29Cisplatin 28Paclitaxel 26Melphalan 26Magnetic Resonance Spectroscopy 26Docetaxel 25Busulfan 25Trabectedin 24apatinib 22Specimen Handling 21Sirolimus 21Antilymphocyte Serum 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2 × avelumab × Sarcoma × Clear all
NCT03006848 2026-02-23

A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma

St. Jude Children's Research Hospital

Phase 2 Completed
19 enrolled 11 charts
Sarcoma

Osteosarcoma

NCT04258956 2025-09-11

AXAGIST

Maria Sklodowska-Curie National Research Institute of Oncology

Phase 2 Completed
58 enrolled
GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT03512834 2018-07-11

ASAP

Dong-A University Hospital

Phase 2 Unknown
32 enrolled
Sarcoma

Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡